(PRWEB) August 09, 2013
CME Outfitters (CMEO), a leading accredited provider in continuing medical education, recently opened registration for its upcoming neuroscienceCME Ask the Expert Q&A Technologies to Advance the Treatment of Alzheimer’s Disease. This live webcast will kick off September 4, 2013 at 1:30pm ET. CMEO’s live webcast features an interactive question and answer session with faculty member Gary W. Small, MD. All participants will have the opportunity to ask their toughest clinical questions regarding Alzheimer’s disease by using the Q&A widget on the webinar screen, email, telephone, and Twitter.
The educational content will focus on Alzheimer’s disease, specifically focusing on the following learning objectives:
- Implement the latest biomarker technologies, such as brain imaging and cerebrospinal fluid analysis, when appropriate, in the management of patients with Alzheimer’s disease.
- Incorporate the new Alzheimer’s disease diagnostic criteria, when appropriate, into clinical practice.
- Enumerate three discussion points that can guide a discussion with patients and their families about the implications of Alzheimer’s disease.
Physicians and other healthcare professionals who work with older adults are encouraged to register.
The American Association for Geriatric Psychiatry (AAGP) and CME Outfitters, LLC, conducted a satellite symposium entitled, Technologies to Advance the Treatment of Alzheimer’s Disease at the AAGP Annual Meeting on March 15, 2013. This live, interactive symposium was captured on video and is available as a certified activity at http://www.neuroscienceCME.com/CM789 and http://www.aagponline.org. Because the opportunity to engage and connect with faculty is critical to physician learning, this follow up live Q&A Webcast has been scheduled to allow clinicians to “Ask the Expert” about content presented during the AAGP symposium. To enhance the learner experience, registrants are encouraged to view the archive of the AAGP symposium prior to participating in the live Q&A. During the Webcast, clinicians will be able to ask questions, discuss clinical case successes and challenges; and gain insight and practice pearls from Gary W. Small, MD. Click on the links below that will take you to the symposium archive, and the registration page for the live Q&A.
Technologies to Advance the Treatment of Alzheimer’s Disease – AAGP symposium archive: http://www.neurosciencecme.com/cmea.asp?ID=789
Technologies to Advance the Treatment of Alzheimer’s Disease – Ask the Expert Q&A:
Faculty and affiliations:
Gary W. Small, MD
Professor of Psychiatry & Biobehavioral Sciences
Parlow-Solomon Professor on Aging
David Geffen School of Medicine
University of California, Los Angeles
Los Angeles, CA
Provided by the American Association for Geriatric Psychiatry. Supported by an educational grant from Lilly USA, LLC. For further information concerning Lilly grant funding, visit http://www.lillygrantoffice.com .
CME Credit (Physicians):
The American Association for Geriatric Psychiatry (AAGP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Association for Geriatric Psychiatry (AAGP) designates this live activity for a maximum of .5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Policy on privacy and confidentiality: Click here to view AAGP’s privacy and confidentiality policy.
Copyright: The American Association for Geriatric Psychiatry owns the copyright for this material or has obtained permission to distribute this material from all speakers.
Disclosure of Relevant Financial Relationships With Commercial Interests
American Association for Geriatric Psychiatry (AAGP) and CME Outfitters, LLC, adhere to the ACCME Standards regarding commercial support of continuing medical education. It is the policy of AAGP and CME Outfitters, LLC, that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved, and also that speakers will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation.
A conflict of interest is created when individuals in a position to control the content of CME have a relevant financial relationship with a commercial interest which therefore may bias his/her opinion and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks or other financial benefits.
AAGP and CME Outfitters will identify, review, and resolve all conflicts of interest that speakers, authors or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
Relevant financial relationships exist between the following individuals and commercial interests:
Dr. Small has disclosed that he serves as a consultant to Eli Lilly and Company; Janssen Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; and Pfizer Inc. He serves on the speaker's bureau of Novartis Pharmaceuticals Corporation.
Christine M. deVries (AAGP staff - planning committee) has nothing to disclose
Marjorie Vanderbilt (AAGP staff - planning committee) has nothing to disclose
Daniel Bateman, MD (content/peer reviewer) has nothing to disclose.
David Beck, MD (content/peer reviewer) has nothing to disclose.
Tatyana P. Shteinlukht, MD, PhD (content/peer reviewer) has nothing to disclose.
Robert Kennedy (planning committee) has nothing to disclose.
Joy Bartnett Leffler, MLA, NASW, CSE (planning committee) has nothing to disclose.
Sandra Haas Binford, MAEd (planning committee) has nothing to disclose.
Sharon Tordoff, CCMEP (planning committee) has nothing to disclose.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
AAGP, CME Outfitters, LLC, the faculty, and Lilly USA, LLC do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
About CME Outfitters, LLC
CME Outfitters develops and distributes live, recorded and web-based, outcomes- and evidence-based educational activities to thousands of clinicians each year and offers expert accreditation and outcome services for non-accredited organizations. CME Outfitters focuses on delivering education to specialty audiences, with strong expertise in neuroscience, inflammatory, infectious, and autoimmune diseases, and cardiovascular disease. For a complete list of certified activities and more information, visit http://www.cmeoutfitters.com or call 877.CME.PROS (877.263.7767).
neuroscienceCME.com is an award-winning web portal serving clinicians, educators, and researchers in the neurosciences. Launched in October 2006, neuroscienceCME.com fills an identified gap in online resources for professionals around the world who practice in areas related to psychiatry, sleep disorders, pain, and neurology. The site's primary mission is to be a central forum for accessing, debating, synthesizing, and implementing the latest findings and best practices in the neurosciences. Visit http://www.neuroscienceCME.com to learn more.
“CME Outfitters …
Improving Clinical Behavior … One Change at a Time”